EDGAR Filing Documents for 0001176256-15-000124

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-15-000124

Filing Date

2015-03-31

Accepted

2015-03-31 15:49:30

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED DECEMBER 31, 2014	nymox6kar141231.htm	6-K	5656
2	ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2014	exhibit99-1.htm	EX-99.1	790580
3	CEO CERTIFICATIONS	exhibit99-2.htm	EX-99.2	6799
4	CFO CERTIFICATIONS	exhibit99-3.htm	EX-99.3	6734
5		exhibit99-1x1x1.jpg	GRAPHIC	11136
6		exhibit99-1x21x1.jpg	GRAPHIC	7324
7		exhibit99-1x22x1.jpg	GRAPHIC	3801
8		exhibit99-1x22x2.jpg	GRAPHIC	6677
	Complete submission text file	0001176256-15-000124.txt		851217

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 15739017
SIC: 2835 In Vitro & In Vivo Diagnostic Substances